Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. - Wikidata - awgldk - TriplyDB

Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium.

Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium.

http://www.wikidata.org/entity/Q36845491

about

Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation.Inflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged Sword Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia Myocardial infarction and remodeling in mice: effect of reperfusion.Macrophage roles following myocardial infarction Evaluation of Cardiac Function by Transthoracic Echocardiography in Subjects with ST-Segment Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention according to Valsartan Dose: The Valsartan One Center Trial.Monocyte chemoattractant protein-1 and coronary artery disease.Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2 Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.The inflammatory response in myocardial injury, repair, and remodelling.Chemokines and the inflammatory response following cardiopulmonary bypass--a new target for therapeutic intervention?--A review.Chemokine receptor-dependent alloresponses.Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.Evidence for an active inflammatory process in the hibernating human myocardium Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.Microglia and ischemic stroke: a double-edged sword.Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice.The immune system and cardiac repair.Targeting inflammatory pathways in myocardial infarction.Induction of early biomarkers in a thrombus-induced sheep model of ischemic heart failure Chemokines and cardiac fibrosis.Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.The inflammatory response and cardiac repair after myocardial infarction.Role of monocyte chemoattractant protein-1 in myocardial infarction.Targeting the chemokines in cardiac repair.Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.Cellular recruitment in myocardial ischaemia/reperfusion injury.The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Anti-inflammatory drugs as promising cardiovascular treatments.The role of transforming growth factor (TGF)-β in the infarcted myocardium.The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease.Contrasting Inflammation Resolution during Atherosclerosis and Post Myocardial Infarction at the Level of Monocyte/Macrophage Phagocytic Clearance.Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment Brief murine myocardial I/R induces chemokines in a TNF-alpha-independent manner: role of oxygen radicals.Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris.

P2860

Q24815569-68E07723-4B48-49D2-8C2E-A3D623CE5F83 Q26747421-0636A94C-2566-4156-ADFD-205A9F53088E Q26863633-0CC665B3-C3A6-4DCA-8E45-17B7A1361348 Q28360935-4B485832-61B4-4398-856A-E1A91731D98D Q33178763-02379168-D1D3-47ED-9B24-155B14230E24 Q33802153-FBBCAFF1-78F5-4D32-A925-5FBFBF8369CF Q34201349-22B92D3A-C01E-4847-B043-55CD06C22B8A Q34631140-7925FF6E-11F3-438C-B1E0-DF296987C864 Q35013388-CA5C874F-89E5-4A38-A263-F4796EAF7CC9 Q35083426-27DD2144-67C7-483D-8A06-E9C08CCE7B74 Q35529656-CD2586C9-6723-4B34-8478-0ED8C7171EF1 Q35554997-FA7CF23D-A696-4C49-AAA4-124916802B48 Q35583497-A3D43E8E-B568-409B-A036-988C57330854 Q35763752-CD0FBF8A-5BD2-411A-BC47-FFC127F21C7D Q35788998-52DE62F5-CC0C-437A-B765-A4E18741A970 Q36230443-BB42938C-A75C-4D48-9F4A-28065A70675D Q36399896-C11AF079-8001-42CD-A1F9-96EA8B3D4422 Q36509613-F9B2709F-A4EF-4049-855A-88519951EFC1 Q36893695-ECB1E616-CFEF-4A6D-99E4-684235108603 Q36907206-3D933CF8-38AC-4F21-A58C-C9A6B2392A48 Q37096652-F7C8ACE6-D758-434E-9D06-BC187A8DEE03 Q37100838-5D7C2DDC-EE27-4136-9C52-871EE37E6B20 Q37369965-3C209246-6359-449F-89E8-53DE061AE68E Q37502208-3D818688-9F87-4383-ACC4-D86F37946AC4 Q37536067-82176A3F-5571-4DFE-B762-6841A690C948 Q37641794-3859AF81-E48A-4AC8-BEF6-A15612EDB541 Q38106962-877B8F4E-2085-44B1-A7D2-B6915B4C3FC0 Q38120799-B51E06F8-AD8D-44C3-A7C6-62FDC7EFA8FC Q38560476-C6CCAEC8-3B4C-4DAA-9DA3-1D310F52CDF4 Q38811208-53FA6832-C294-44CF-B3DD-A8EDB298BD80 Q38875774-14624BA9-3A02-46C9-AADD-274905C88174 Q39051784-D2FB39C7-56AD-4A44-AAC4-82306EC70FC2 Q39265526-32AC8D63-293D-49B2-9DF2-D21372232083 Q40393639-9112F6EE-CA49-4D1B-91CF-3A53C1BD291F Q42144621-86C6BBD6-0F14-453B-A406-146F68E00B24 Q42332637-5A46CEB9-7327-484F-B3B0-EFC008B22134 Q43800019-E3634261-79BA-40F3-B61E-FE6630EACEF9 Q45885035-2823093F-DE3C-4839-9E72-B7D9C392DB8D Q47734765-52431636-7257-47F1-9D88-36F7DF26A641 Q47981043-0ADC8F80-967F-4B86-8BAD-1539302F7424

P2860

Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium.

http://www.wikidata.org/entity/Q36845491

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Induction of monocyte chemoatt ...... reperfused canine myocardium.

@en

type

label

Induction of monocyte chemoatt ...... reperfused canine myocardium.

@en

prefLabel

Induction of monocyte chemoatt ...... reperfused canine myocardium.

@en

P1433

Q36845491-A47D0651-A3E2-4807-AC30-3031ED5C4EAE

P1476

Q36845491-518C7771-F331-4DCA-8A6E-4A8B2721F426

P2093

Q36845491-33C4A24D-6EE8-4C18-AA33-21CEB9ACCE41

Q36845491-38E1514F-AC27-4845-BFAA-E2F17CD64343

Q36845491-4C25838D-1722-4376-854D-56A742337B26

Q36845491-61F6DB1A-4E21-468D-9775-082F8D0A3F45

Q36845491-A9C134B0-FD67-4413-9886-EF9A82956444

Q36845491-B13296E7-CEA7-4D27-8E74-A0548C2DC911

Q36845491-B996A003-B52A-4877-BC48-38ED2866A88C

Q36845491-C2CF290C-DB5B-486E-9B6A-9E074567FB1F

Q36845491-C59BD2F5-93FC-41E2-B2C8-BEA177C8B771

Q36845491-E2C9BD9A-7073-44FB-A191-8EB27BDA57DD

P304

Q36845491-49711F79-80DC-4AD1-869D-9C7456505B67

P31

Q36845491-40192E0F-611F-40BA-A10E-FAA56839F992

P356

Q36845491-BB508FB9-4A5E-4E44-A2D1-12133160B630

P407

Q36845491-099334C1-1E1C-475B-A4C1-31BABF4E3773

P433

Q36845491-176EA643-E558-4A6D-966B-A2670F1DC16D

P478

Q36845491-2958B8EC-61ED-46D6-946E-25113EBF0639

P50

Q36845491-3388C2A1-80A1-4C6E-B61D-27EEDF711195

Q36845491-D0F60A2D-FE68-4C72-9D4B-D396998262EA

P577

Q36845491-554E20DB-DF82-44D9-A29A-FED26AB23B9A

P698

Q36845491-28DB624D-87A6-496E-8003-58A805240C0B

P356

01.CIR.95.3.693

P1433

P1476

Induction of monocyte chemoatt ...... d reperfused canine myocardium

@en

P2093

A G Kumar

http://www.w3.org/2001/XMLSchema#string

C M Ballantyne

http://www.w3.org/2001/XMLSchema#string

C R MacKay

http://www.w3.org/2001/XMLSchema#string

C W Smith

http://www.w3.org/2001/XMLSchema#string

G J LaRosa

http://www.w3.org/2001/XMLSchema#string

G L Kukielka

http://www.w3.org/2001/XMLSchema#string

H H Birdsall

http://www.w3.org/2001/XMLSchema#string

H K Hawkins

http://www.w3.org/2001/XMLSchema#string

L H Michael

http://www.w3.org/2001/XMLSchema#string

M L Entman

http://www.w3.org/2001/XMLSchema#string

P304

693-700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.95.3.693

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Merry L. Lindsey

P577

1997-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9024159

http://www.w3.org/2001/XMLSchema#string